Status:

COMPLETED

Preliminary Validation of an in Vitro Diagnosis-medical Device for Hepatitis B Screening

Lead Sponsor:

University Hospital, Grenoble

Collaborating Sponsors:

MagIA Diagnostics

Conditions:

Hepatitis B

Healthy

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The principal objective of the study is to perform a first step of technical adjustment and preliminary validation of a diagnostic test for hepatitis B (HBsAntigen, anti-HBs Antibody and anti-HBc Anti...

Detailed Description

The diagnosis of hepatitis B in precarious populations is often difficult. The use of a in vitro diagnosis-medical device in point of care could alleviate this difficulty. It would identify whether or...

Eligibility Criteria

Inclusion

  • Group 1: HBsAg negative, Anti HBc negative, Anti HBs negative, during a laboratory assay on serum
  • Group 2: HBsAg negative, Anti HBc negative, Anti HBs positive, during a laboratory assay on serum
  • Group 3: HBsAg negative, Anti HBc positive, Ab anti HBs positive or negative, during a laboratory assay on serum
  • Group 4: HBsAg positive, Anti HBc positive, Anti HBs negative, during a laboratory assay on serum
  • all: affiliated to social security or beneficiary of such a scheme

Exclusion

  • Infection by a confounding factor: HIV, HCV and / or HDV
  • Protected person: Pregnant woman, parturient, mother who is breastfeeding, person deprived of liberty by judicial or administrative decision, person subject to a legal protection measure
  • Exclusion period for other research studies involving the human person
  • Annual threshold of allowances for participation in research involving the affected human person.

Key Trial Info

Start Date :

October 21 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 13 2022

Estimated Enrollment :

40 Patients enrolled

Trial Details

Trial ID

NCT04109625

Start Date

October 21 2019

End Date

May 13 2022

Last Update

May 24 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Clinical research center CIC1406

Grenoble, France, 38000